Phase 1 study of two merozoite surface protein 1 (MSP1(42)) vaccines for Plasmodium falciparum malaria.

Malkin, Elissa; Long, Carole A; Stowers, Anthony W; Zou, Lanling; Singh, Sanjay; MacDonald, Nicholas J; Narum, David L; Miles, Aaron P; Orcutt, Andrew C; Muratova, Olga; Moretz, Samuel E; Zhou, Hong; Diouf, Ababacar; Fay, Michael; Tierney, Eveline; Leese, Philip; Mahanty, Siddhartha; Miller, Louis H; Saul, Allan; Martin, Laura B

Malkin, Elissa; Long, Carole A; Stowers, Anthony W; Zou, Lanling; Singh, Sanjay; MacDonald, Nicholas J; Narum, David L; Miles, Aaron P; Orcutt, Andrew C; Muratova, Olga; Moretz, Samuel E; Zhou, Hong; Diouf, Ababacar; Fay, Michael; Tierney, Eveline; Leese, Philip; Mahanty, Siddhartha; Miller, Louis H; Saul, Allan; Martin, Laura B.

Afiliação

Malkin E; Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.

PLoS Clin Trials ; 2(4): e12, 2007.

Article em En | MEDLINE | ID: mdl-17415408

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Idioma: En Revista: PLoS Clin Trials Ano de publicação: 2007 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google